Regulation of Smad signaling through a differential recruitment of coactivators and corepressors by ZEB proteins
Open accessThe DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases
Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H., & Nakatani, Y. (1996) · Cell · doi:10.1016/s0092-8674(00)82001-2 · Cited by 2,952
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
Massagué, J., Blain, S. W., & Lo, R. S. (2000) · Cell · doi:10.1016/s0092-8674(00)00121-5 · Cited by 2,385
Controlling TGF-beta signaling.
Massagué, J., & Chen, Y. (2000) · PubMed · Cited by 1,976
NEW EMBO MEMBERS REVIEW: Transcriptional control by the TGF-beta/Smad signaling system
Massague, J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.8.1745 · Cited by 1,966
The CBP co-activator is a histone acetyltransferase
Bannister, A. J., & Kouzarides, T. (1996) · Nature · doi:10.1038/384641a0 · Cited by 1,805
CBP/p300 in cell growth, transformation, and development
Goodman, R. H., & Smolik, S. (2000) · Genes & Development · doi:10.1101/gad.14.13.1553 · Cited by 1,778
A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A
Yang, X.-J., Ogryzko, V. V., Nishikawa, J.-I., Howard, B. H., & Nakatani, Y. (1996) · Nature · doi:10.1038/382319a0 · Cited by 1,479
The Two-Handed E Box Binding Zinc Finger Protein SIP1 Downregulates E-Cadherin and Induces Invasion
Comijn, J., Berx, G., Vermassen, P., Verschueren, K., van Grunsven, L., Bruyneel, E., Mareel, M., Huylebroeck, D., & van Roy, F. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00260-x · Cited by 1,394
Acetylation: a regulatory modification to rival phosphorylation?
Kouzarides, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.6.1176 · Cited by 1,160
Cited by
Molecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091
Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype?
Peinado, H., Olmeda, D., & Cano, A. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2131 · Cited by 3,121
TGF-β-induced epithelial to mesenchymal transition
Xu, J., Lamouille, S., & Derynck, R. (2009) · Cell Research · doi:10.1038/cr.2009.5 · Cited by 2,804
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
Singh, A., & Settleman, J. (2010) · Oncogene · doi:10.1038/onc.2010.215 · Cited by 2,545
“Notably, Smads associate with Zeb proteins (Zeb1 and Zeb2/ SIP1) to repress expression of E-cadherin during the initiation of EMT (Verschueren et al., 1999; Comijn et al., 2001; Postigo et al., 2003).”
BackgroundSPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS
Feng, X.-H., & Derynck, R. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.022404.142018 · Cited by 1,869
“SIP1 interacts with the MH2 domains of Smads (Postigo 2003, Verschueren et al. 1999) and represses Smadmediated transcription depending on a DNA sequence that allows SIP1 binding (Comijn et al. 2001).”
BackgroundInfluentialTGF-β and epithelial-to-mesenchymal transitions
Zavadil, J., & Böttinger, E. P. (2005) · Oncogene · doi:10.1038/sj.onc.1208927 · Cited by 1,578
TGF-β signaling in health, disease and therapeutics
Deng, Z., Fan, T., Xiao, C., Tian, H., Zheng, Y., Li, C., & He, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01764-w · Cited by 1,168
The ZEB/miR‐200 feedback loop—a motor of cellular plasticity in development and cancer?
Brabletz, S., & Brabletz, T. (2010) · EMBO reports · doi:10.1038/embor.2010.117 · Cited by 793
E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer
Schmalhofer, O., Brabletz, S., & Brabletz, T. (2009) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9179-y · Cited by 765
Voulgari, A., & Pintzas, A. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.03.002 · Cited by 671
ZEB1: At the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance
Zhang, P., Sun, Y., & Ma, L. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1006048 · Cited by 611
“On the other hand, by recruiting p300-P/CAF and Smad proteins, ZEB1 can activate the transcription of TGF-b-responsive genes and promote osteoblastic differentiation.(26,27) In MDAMB-231 human breast cancer cells, knockdown of ZEB1 resulted in upregulation of »200 genes and downregulation of »30 genes, most of which a…”
BackgroundGregory, P. A., Bracken, C. P., Smith, E., Bert, A. G., Wright, J. A., Roslan, S., Morris, M., Wyatt, L., Farshid, G., Lim, Y.-Y., et al. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-02-0103 · Cited by 552
Actions of TGF-β as tumor suppressor and pro-metastatic factor in human cancer
Pardali, K., & Moustakas, A. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.06.004 · Cited by 526
Non-redundant functions of EMT transcription factors
Stemmler, M. P., Eccles, R. L., Brabletz, S., & Brabletz, T. (2019) · Nature Cell Biology · doi:10.1038/s41556-018-0196-y · Cited by 524
EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness
Sánchez-Tilló, E., Liu, Y., de Barrios, O., Siles, L., Fanlo, L., Cuatrecasas, M., Darling, D. S., Dean, D. C., Castells, A., & Postigo, A. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1122-2 · Cited by 518
Self-citationMicroRNAs as regulators of epithelial-mesenchymal transition
Gregory, P. A., Bracken, C. P., Bert, A. G., & Goodall, G. J. (2008) · Cell Cycle · doi:10.4161/cc.7.20.6851 · Cited by 506
Sánchez-Tilló, E., Lázaro, A., Torrent, R., Cuatrecasas, M., Vaquero, E. C., Castells, A., Engel, P., & Postigo, A. (2010) · Oncogene · doi:10.1038/onc.2010.102 · Cited by 504
Self-citationRegulation of EMT in Colorectal Cancer: A Culprit in Metastasis
Vu, T., & Datta, P. (2017) · Cancers · doi:10.3390/cancers9120171 · Cited by 496
The role of the ZEB family of transcription factors in development and disease
Vandewalle, C., Van Roy, F., & Berx, G. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8465-8 · Cited by 486
Neural induction: old problem, new findings, yet more questions
Stern, C. D. (2005) · Development · doi:10.1242/dev.01794 · Cited by 421
Zinc finger proteins in cancer progression
Jen, J., & Wang, Y.-C. (2016) · Journal of Biomedical Science · doi:10.1186/s12929-016-0269-9 · Cited by 412
Graham, T. R., Zhau, H. E., Odero-Marah, V. A., Osunkoya, A. O., Kimbro, K. S., Tighiouart, M., Liu, T., Simons, J. W., & O'Regan, R. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2559 · Cited by 384
EMT Factors and Metabolic Pathways in Cancer
Georgakopoulos-Soares, I., Chartoumpekis, D. V., Kyriazopoulou, V., & Zaravinos, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00499 · Cited by 349
Shirakihara, T., Saitoh, M., & Miyazono, K. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-03-0249 · Cited by 320
Momen-Heravi, F., Saha, B., Kodys, K., Catalano, D., Satishchandran, A., & Szabo, G. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0623-9 · Cited by 307
ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types
Lehmann, W., Mossmann, D., Kleemann, J., Mock, K., Meisinger, C., Brummer, T., Herr, R., Brabletz, S., Stemmler, M. P., & Brabletz, T. (2016) · Nature Communications · doi:10.1038/ncomms10498 · Cited by 305
Zeb1 links epithelial-mesenchymal transition and cellular senescence
Liu, Y., El-Naggar, S., Darling, D. S., Higashi, Y., & Dean, D. C. (2008) · Development · doi:10.1242/dev.007047 · Cited by 303
Opposing functions of ZEB proteins in the regulation of the TGFbeta/BMP signaling pathway
Postigo, A. A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg225 · Cited by 294
Self-citationEpithelial–mesenchymal transition and its transcription factors
Debnath, P., Huirem, R. S., Dutta, P., & Palchaudhuri, S. (2022) · Bioscience Reports · doi:10.1042/bsr20211754 · Cited by 281
Regulation of the latent-lytic switch in Epstein–Barr virus
Kenney, S. C., & Mertz, J. E. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.01.002 · Cited by 281
TGF-β in developmental and fibrogenic EMTs
Lee, J. H., & Massagué, J. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.09.004 · Cited by 278
Li, A., Omura, N., Hong, S.-M., Vincent, A., Walter, K., Griffith, M., Borges, M., & Goggins, M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4227 · Cited by 272
Epithelial-to-Mesenchymal Transition: Epigenetic Reprogramming Driving Cellular Plasticity
Skrypek, N., Goossens, S., De Smedt, E., Vandamme, N., & Berx, G. (2017) · Trends in Genetics · doi:10.1016/j.tig.2017.08.004 · Cited by 271
Fibroblast activation and myofibroblast generation in obstructive nephropathy
Grande, M. T., & López-Novoa, J. M. (2009) · Nature Reviews Nephrology · doi:10.1038/nrneph.2009.74 · Cited by 265
The Transcriptional Corepressor CtBP: A Foe of Multiple Tumor Suppressors
Chinnadurai, G. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3349 · Cited by 264
ZEB/miR‐200 feedback loop: At the crossroads of signal transduction in cancer
Hill, L., Browne, G., & Tulchinsky, E. (2013) · International Journal of Cancer · doi:10.1002/ijc.27708 · Cited by 261
Zhao, L., Liu, Y., Zhang, J., Liu, Y., & Qi, Q. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1886-5 · Cited by 214
Suppression of the Epithelial–Mesenchymal Transition by Grainyhead-like-2
Cieply, B., Riley, P., Pifer, P. M., Widmeyer, J., Addison, J. B., Ivanov, A. V., Denvir, J., & Frisch, S. M. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4038 · Cited by 210
“Previous work has shown that ZEB1 protein can bind to the Smad2/3 complex, enhancing transactivation (39); our preliminary observations indicated that this mechanism did not apply in our system.”
BackgroundInterplay between Notch1 and Notch3 promotes EMT and tumor initiation in squamous cell carcinoma
Natsuizaka, M., Whelan, K. A., Kagawa, S., Tanaka, K., Giroux, V., Chandramouleeswaran, P. M., Long, A., Sahu, V., Darling, D. S., Que, J., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01500-9 · Cited by 203
Sheng, G., dos Reis, M., & Stern, C. D. (2003) · Cell · doi:10.1016/s0092-8674(03)00927-9 · Cited by 198
Jiang, H., Wei, H., Wang, H., Wang, Z., Li, J., Ou, Y., Xiao, X., Wang, W., Chang, A., Sun, W., et al. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-04632-z · Cited by 185
Hu, D., & Marcucio, R. S. (2009) · Development · doi:10.1242/dev.026583 · Cited by 183
“Interestingly, Zfhx1b is thought to act primarily as a transcriptional repressor of Tgfβ/Bmp signaling (Postigo, 2003; Postigo et al., 2003), and coordinated Bmp signaling is required for development of this region of the face (e.”
BackgroundTGF-β-induced fibrosis: A review on the underlying mechanism and potential therapeutic strategies
Ong, C. H., Tham, C. L., Harith, H. H., Firdaus, N., & Israf, D. A. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174510 · Cited by 183
Weng, Q., Chen, Y., Wang, H., Xu, X., Yang, B., He, Q., Shou, W., Chen, Y., Higashi, Y., van den Berghe, V., et al. (2012) · Neuron · doi:10.1016/j.neuron.2011.12.021 · Cited by 163
“Sip1 is a multidomain zinc-finger E-box-binding homeobox transcription factor that may also interact with many distinct protein complexes other than p-Smads, such as CtBP (Postigo et al., 2003) and the NuRD chromatin remodeling complex (Verstappen et al.”
Transcriptional regulation of EMT transcription factors in cancer
Saitoh, M. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.10.001 · Cited by 162
Yi, Y., Xie, H., Xiao, X., Wang, B., Du, R., Liu, Y., Li, Z., Wang, J., Sun, L., Deng, Z., et al. (2018) · Aging · doi:10.18632/aging.101383 · Cited by 39
MicroRNA-128-3p Alleviates Neuropathic Pain Through Targeting ZEB1
Zhang, X., Zhang, Y., Cai, W., Liu, Y., Liu, H., Zhang, Z., & Su, Z. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.134946 · Cited by 30
Nanoparticle mediated alteration of EMT dynamics: an approach to modulate cancer therapeutics
Sen, P., Saha, M., & Ghosh, S. S. (2020) · Materials Advances · doi:10.1039/d0ma00455c · Cited by 21
Metadata
- Authors
- Postigo, A. A.
- Venue
- The EMBO Journal
- Published
- 2003-05-15
- Volume
- 22
- Issue
- 10
- Pages
- 2453-2462
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- OpenAlex
- W2036401671
- Cited by
- 387
- References
- 72
- FWCI
- 3.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.